TrialDiabetologia2020

Risk of hypoglycaemia with insulin degludec versus insulin glargine U300 in insulin-treated patients with type 2 diabetes: the randomised, head-to-head CONCLUDE trial.

Athena Philis-Tsimikas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.